Drugs / GSNO
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04619602 | Aug → Sep 2025 | bronchopulmonary dysplasia | University Hospitals Cleveland Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSNO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04619602 ↗ |
| Route | Inhaled | “30 minutes of inhaled GSNO agent” NCT04619602 ↗ |